Sarcopenia: revised European consensus on definition and diagnosis.

Background in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order...

Descripción completa

Detalles Bibliográficos
Publicado en:Age & Ageing Vol. 48; no. 1; pp. 16 - 32
Autores principales: Cruz-Jentoft, Alfonso J, Bahat, Gülistan, Bauer, Jürgen, Boirie, Yves, Bruyère, Olivier, Cederholm, Tommy, Cooper, Cyrus, Landi, Francesco, Rolland, Yves, Sayer, Avan Aihie, Schneider, Stéphane M, Sieber, Cornel C, Topinkova, Eva, Vandewoude, Maurits, Visser, Marjolein, Zamboni, Mauro, (EWGSOP2), Writing Group for the European Working Group on Sarcopenia in Older People 2
Formato: Artículo
Publicado: Oxford University Press / USA Jan2019
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=134019073&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 134019073
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00020729
        AGA
      jtl: Age & Ageing
      issn: 00020729
      maglogo: N
    pubinfo:
      dt: Jan2019
      vid: 48
      iid: 1
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        134019073
        10.1093/ageing/afy169
      ppf: 16
      ppct: 16
      formats:
      tig:
        atl: Sarcopenia: revised European consensus on definition and diagnosis.
      aug:
        au:
          Cruz-Jentoft, Alfonso J
          Bahat, Gülistan
          Bauer, Jürgen
          Boirie, Yves
          Bruyère, Olivier
          Cederholm, Tommy
          Cooper, Cyrus
          Landi, Francesco
          Rolland, Yves
          Sayer, Avan Aihie
          Schneider, Stéphane M
          Sieber, Cornel C
          Topinkova, Eva
          Vandewoude, Maurits
          Visser, Marjolein
          Zamboni, Mauro
          (EWGSOP2), Writing Group for the European Working Group on Sarcopenia in Older People 2
        affil:
          Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
          Department of Internal Medicine, Division of Geriatrics, Istanbul Medical School, Istanbul University, Istanbul, Turkey
          Center for Geriatric Medicine, University Heidelberg, Agaplesion Bethanien Krankenhaus, Heidelberg, Germany
          Research Department, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France
          Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium
          Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, and Theme Ageing, Karolinska University Hospital, Stockholm, Sweden
          MRC Lifecourse Epidemiology Unit, University of Southampton; Southampton, UK; and Department of Epidemiology, University of Oxford, OX, UK
          Instituto di Medicina Interna e Geriatria, Università Cattolica del Sacro Cuore, Roma, Italy
          Department of Geriatrics, Hospital and University of Toulouse, Toulouse, France
          NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust and Faculty of Medical Sciences, Newcastle University, Newcastle, UK
          Department of Gastroenterology and Clinical Nutrition, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France
          Department of Internal Medicine-Geriatrics, Institute for Biomedicine and Ageing, Friedrich-Alexander-University, Erlangen-Nürnberg, Germany
          Department of Geriatrics, First Faculty of Medicine, Charles University and General Faculty Hospital, Prague, Czech Republic
          Department Geriatrics, University of Antwerp, Ziekenhuisnetwerk Antwerpen (ZNA), Antwerp, Belgium
          Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam; and the Amsterdam Public Health Research Institute; Amsterdam, The Netherlands
          Department of Medicine, Geriatric section, University of Verona, Verona, Italy
      su:
        Europe
        Elder care
        Disease risk factors
        Sarcopenia
        Algorithms
        Economic aspects of diseases
        Muscle strength
        Body movement
        Severity of illness index
        Early diagnosis
        Diagnosis
      sug:
        subj:
          Elder care
          Disease risk factors
          Europe
          Continuing Care Retirement Communities
          Sarcopenia
          Algorithms
          Economic aspects of diseases
          Muscle strength
          Body movement
          Severity of illness index
          Early diagnosis
          Diagnosis
      keyword:
        EWGSOP2
        muscle assessment
        muscle strength
        older people
        physical performance
        sarcopenia
        EWGSOP2
        muscle assessment
        muscle strength
        older people
        physical performance
        sarcopenia
      ab: Background in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings. Objectives to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia. Recommendations sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia. Conclusions EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N